Leveraging extended-release buprenorphine to improve care for opioid use disorder in the criminal-legal system

Am J Drug Alcohol Abuse. 2024 Sep 2;50(5):619-622. doi: 10.1080/00952990.2024.2401980. Epub 2024 Oct 9.

Author

Sean M Murphy^{1

2}

Affiliations

¹ Weill Cornell Medicine, Cornell University, New York, NY, USA.
² Weill Cornell Medicine, Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (CHERISH), New York, NY, USA.

PMID: 39382557
DOI: 10.1080/00952990.2024.2401980

No abstract available

Keywords: Opioid use disorder; criminal-legal; extended-release buprenorphine; medications for opioid use disorder.

Grants and funding

P30 DA040500/DA/NIDA NIH HHS/United States